首页> 外文期刊>The Journal of Allergy and Clinical Immunology >A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis
【24h】

A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis

机译:雷帕霉素复合物的机械靶标1/2(mTorc1)/ V-akt鼠胸腺瘤病毒癌基因同源物1(akt1)/组织蛋白酶H轴控制皮肤中的叶片表达和加工,一种新的皮肤屏障患者皮肤屏障中断的特应性皮炎患者

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Filaggrin, which is encoded by the filaggrin gene (FLG), is an important component of the skin's barrier to the external environment, and genetic defects in FLG strongly associate with atopic dermatitis (AD). However, not all patients with AD have FLG mutations.
机译:背景:由Filaggrin基因(FLG)编码的Filaggrin是皮肤对外部环境的障碍的重要组成部分,并且FLG中的遗传缺陷强烈与特应性皮炎(AD)相关联。 然而,并非所有患者都有FLG突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号